Article
Mapping the Pathways of Resistance to Targeted Therapies
21 Sept 2015
Abstract excerpt
Resistance substantially limits the depth and duration of clinical responses to targeted anticancer therapies. Through the use of complementary experimental approaches, investigators have revealed that cancer cells can achieve resistance through adaptation or selection driven by specific genetic, epigenetic, or microenvironmental alterations. Ultimately, these diverse alterations often lead to the activation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
